Tiny income, big dreams: can True Health become the next robotics champion?
The developer of medical devices is aiming to open up a commanding lead in the niche market for puncture and ablation robots, with the help of IPO proceeds Key Takeaways:…
FAST NEWS: Fosun Pharma’s Revenue Growth Slows Sharply in Third Quarter
The latest: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) said Sunday its revenue increased 1.7% year-on-year to 10.27 billion yuan ($1.4 billion) in the third quarter, as measured using…
RELATED ARTICLES
-
Despite years of losses, Hai Robotics has some strong selling points
- Galaxis hitches ride on Hong Kong robotics bandwagon
- The embodied intelligence puzzle: A deep dive into China’s humanoid robot industry
- The new smart home: Where robots handle chores and provide companionship
- Iplusmobot motors towards Hong Kong IPO, banking on big-name backers
- Geekplus’ industrial robots fail to dazzle investors
- PsiBot’s $280 million fundraising bets on the brains behind embodied AI
